Gain Therapeutics (GANX) Return on Sales [ROS] (2020 - 2026)
Gain Therapeutics (GANX) posted Return on Sales [ROS] of -40328.26% for Q4 2023, down 27640.16 percentage points from -12688.10% a year earlier but up 279.03 percentage points from the prior quarter.
Powered by 
Analysis
Gain Therapeutics (GANX) Return on Sales [ROS] (2020 - 2026) Analysis & Trends
Since Q1 2020, Gain Therapeutics has reported Return on Sales [ROS] for 16 quarters.
- Annual Return on Sales [ROS] shows a three-year change of -28280.72 percentage points (FY2020 to FY2023).
- In prior years, Gain Therapeutics' Return on Sales [ROS] was -12688.10% in FY2022 (-4308.30 pp), -8379.80% in FY2021 (+3667.73 pp) and -12047.54% in FY2020.
- Quarterly Return on Sales [ROS] has run from a low of -46819.42% in Q1 2021 to a high of -3941.29% in Q2 2021 over five years.
- On a year-over-year basis, Return on Sales [ROS] has declined in each of the last five quarters, with an average year-over-year change of -6954.64 percentage points over the last eight quarters.
- The strongest year-over-year quarter for Return on Sales [ROS] in the past five years was Q1 2022, with a gain of 39512.66 percentage points; the weakest was Q1 2021, with a drop of 39142.81 percentage points.
- According to Business Quant data, Return on Sales [ROS] for the three prior quarters was -40607.29% (Q3 2023), -40364.41% (Q2 2023) and -9477.68% (Q1 2023).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,128.99 Bn | 1,097.58 Bn | 19.71 Bn | 51.16% |
| 2 | Johnson & Johnson | 634.51 Bn | 554.37 Bn | 17.30 Bn | 24.35% |
| 3 | AbbVie | 505.90 Bn | 479.01 Bn | 12.70 Bn | 37.86% |
| 4 | Merck | 357.53 Bn | 311.91 Bn | 12.21 Bn | -3.52% |
| 5 | Novartis Ag | 289.94 Bn | 253.93 Bn | 11.24 Bn | 32.97% |
| 6 | Astrazeneca | 265.41 Bn | 239.09 Bn | 12.86 Bn | 20.57% |
| 7 | Amgen | 238.14 Bn | 193.54 Bn | 7.24 Bn | 34.95% |
| 8 | Gilead Sciences | 194.79 Bn | 168.99 Bn | 6.22 Bn | -133.21% |
| 9 | Pfizer | 171.00 Bn | 117.64 Bn | 10.94 Bn | 28.37% |
| 10 | Gain Therapeutics | 54.89 Mn | -4.40 Mn | - | -7,667.05% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -7,667.05% |
| Mar 31, 2026 | -5,753.28% |
| Dec 31, 2025 | -5,358.86% |
| Sep 30, 2025 | -6,129.80% |
| Jun 30, 2025 | -11,956.23% |
| Mar 31, 2025 | -10,811.81% |
| Dec 31, 2023 | -40,328.26% |
| Sep 30, 2023 | -40,607.29% |
| Jun 30, 2023 | -40,364.41% |
| Mar 31, 2023 | -9,477.68% |
| Dec 31, 2022 | -12,688.10% |
| Sep 30, 2022 | -8,959.73% |
| Jun 30, 2022 | -5,442.98% |
| Mar 31, 2022 | -7,306.75% |
| Dec 31, 2021 | -7,426.33% |
| Sep 30, 2021 | -16,953.46% |
| Jun 30, 2021 | -3,941.29% |
| Mar 31, 2021 | -46,819.42% |
| Dec 31, 2020 | -17,678.47% |
| Sep 30, 2020 | -12,232.51% |
API Access
Gain Therapeutics Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=GANX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "GANX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=GANX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();